These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 187356)

  • 21. Effect of clonidine on sleep patterns in man.
    Autret A; Minz M; Beillevaire T; Cathala HP; Schmitt H
    Eur J Clin Pharmacol; 1977 Dec; 12(5):319-22. PubMed ID: 598402
    [TBL] [Abstract][Full Text] [Related]  

  • 22. REM sleep suppression by monoamine reuptake blockade: development of tolerance with repeated drug administration.
    Ross RJ; Ball WA; Gresch PJ; Morrison AR
    Biol Psychiatry; 1990 Aug; 28(3):231-9. PubMed ID: 2165825
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reduced clonidine rapid eye movement sleep suppression in patients with primary major affective illness.
    Schittecatte M; Charles G; Machowski R; Garcia-Valentin J; Mendlewicz J; Wilmotte J
    Arch Gen Psychiatry; 1992 Aug; 49(8):637-42. PubMed ID: 1322119
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bupropion-Induced Nightmares Treated With Clonidine.
    Mathews M; Mathews N; Jamal F; Papa-Molter A
    Prim Care Companion CNS Disord; 2019 Oct; 21(5):. PubMed ID: 31600431
    [No Abstract]   [Full Text] [Related]  

  • 25. Role of noradrenergic and GABA-ergic inputs in pedunculopontine tegmentum for regulation of rapid eye movement sleep in rats.
    Pal D; Mallick BN
    Neuropharmacology; 2006 Jul; 51(1):1-11. PubMed ID: 16616214
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Presynaptic alpha 2-adrenoceptor function and sleep in man: studies with clonidine and idazoxan.
    Nicholson AN; Pascoe PA
    Neuropharmacology; 1991 Apr; 30(4):367-72. PubMed ID: 1677168
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Minireview. Catecholamines and the sleep-wake cycle. II. REM sleep.
    Monti JM
    Life Sci; 1983 Mar; 32(13):1401-15. PubMed ID: 6132316
    [No Abstract]   [Full Text] [Related]  

  • 28. Disturbances of sleep and wakefulness associated with the use of antihypertensive agents.
    Monti JM
    Life Sci; 1987 Oct; 41(17):1979-88. PubMed ID: 2890073
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of alpha 2-adrenergic drugs on REM sleep deprivation-induced increase in swimming activity.
    Asakura W; Matsumoto K; Ohta H; Watanabe H
    Pharmacol Biochem Behav; 1993 Sep; 46(1):111-5. PubMed ID: 7902978
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Involvement of peripheral alpha2A adrenoceptor in the acceleration of gastrointestinal transit and abdominal visceral pain induced by intermittent deprivation of REM sleep.
    Yaoita F; Muto M; Murakami H; Endo S; Kozawa M; Tsuchiya M; Tadano T; Tan-No K
    Physiol Behav; 2018 Mar; 186():52-61. PubMed ID: 29338982
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of a D2 receptor agonist RO 41-9067 alone and with clonidine on sleep parameters in the rat.
    Python A; de Saint Hilaire Z; Gaillard JM
    Pharmacol Biochem Behav; 1996 Feb; 53(2):291-6. PubMed ID: 8808134
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Translational evaluation of JNJ-18038683, a 5-hydroxytryptamine type 7 receptor antagonist, on rapid eye movement sleep and in major depressive disorder.
    Bonaventure P; Dugovic C; Kramer M; De Boer P; Singh J; Wilson S; Bertelsen K; Di J; Shelton J; Aluisio L; Dvorak L; Fraser I; Lord B; Nepomuceno D; Ahnaou A; Drinkenburg W; Chai W; Dvorak C; Sands S; Carruthers N; Lovenberg TW
    J Pharmacol Exp Ther; 2012 Aug; 342(2):429-40. PubMed ID: 22570363
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy of the 'clonidine REM suppression test (CREST)' to separate patients with major depression from controls; a comparison with three currently proposed biological markers of depression.
    Schittecatte M; Garcia-Valentin J; Charles G; Machowski R; Pena-Othaitz MJ; Mendlewicz J; Wilmotte J
    J Affect Disord; 1995 Mar; 33(3):151-7. PubMed ID: 7790666
    [TBL] [Abstract][Full Text] [Related]  

  • 34. REM sleep inhibition by desipramine: evidence for an alpha-1 adrenergic mechanism.
    Ross RJ; Gresch PJ; Ball WA; Sanford LD; Morrison AR
    Brain Res; 1995 Dec; 701(1-2):129-34. PubMed ID: 8925274
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of disulfiram on the sleep of chronic alcoholics.
    Snyder S; Karacan I; Salis PJ
    Curr Alcohol; 1981; 8():159-66. PubMed ID: 6282542
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Beta-adrenergic receptors and paradoxical sleep in the rat].
    Lanfumey L; Adrien J
    C R Seances Acad Sci III; 1981 Mar; 292(9):645-7. PubMed ID: 6263513
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preliminary trial of the noradrenergic agonist clonidine in psychiatric patients.
    Jimerson DC; Post RM; Stoddard FJ; Gillin JC; Bunney WE
    Biol Psychiatry; 1980 Feb; 15(1):45-57. PubMed ID: 7357058
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of clonidine and alpha-methyl-p-tyrosine on the carbachol stimulation of paradoxical sleep.
    Mastrangelo D; de Saint Hilaire-Kafi Z; Gaillard JM
    Pharmacol Biochem Behav; 1994 May; 48(1):93-100. PubMed ID: 7913234
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Studies on the possible contribution of a peripheral presynaptic action of clonidine and dopamine to their vascular effects under in vivo conditions.
    Haeusler G
    Naunyn Schmiedebergs Arch Pharmacol; 1976 Dec; 295(3):191-202. PubMed ID: 189225
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impairment of environmental effects on brain weight by adrenergic drugs in rats.
    Pearlman C
    Physiol Behav; 1983 Jan; 30(1):161-3. PubMed ID: 6836040
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.